SIRT1 and NAD+ precursors: Therapeutic targets in multiple sclerosis a review

Neurodegeneration is an important determinant of disability in multiple sclerosis (MS) but while currently approved treatments reduce inflammation, they have not been shown to reduce neurodegeneration. SIRT1, a NAD dependent protein deacetylase, has been implicated in the pathogenesis of neurodegene...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Neuroimmunol
Main Authors: Nimmagadda, Vamshi K.C., Makar, Tapas K., Chandrasekaran, Krish, Sagi, Avinash Rao, Ray, Jayanta, Russell, James W., Bever, Christopher T.
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528149/
https://ncbi.nlm.nih.gov/pubmed/27474445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jneuroim.2016.07.007
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares